Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ:TVGN)

1.080 +0.080 (+8.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 686,396
Open 1.040
Bid (Size) 1.060 (2)
Ask (Size) 1.100 (61)
Prev. Close 1.000
Today's Range 0.9800 - 1.110
52wk Range 0.2556 - 3.090
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tevogen Announces Tevogen Generics, a New Effort in Support of President Trump’s Initiative to Encourage Pharmaceutical Manufacturing in United States
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
From Tevogen Bio Inc
Via GlobeNewswire

Performance

YTD
+1.9%
+1.9%
1 Month
-2.7%
-2.7%
3 Month
-25.5%
-25.5%
6 Month
+184.5%
+184.5%
1 Year
-56.3%
-56.3%

More News

Read More
Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s CIO & Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauer’s AI Discussion Panel
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio's T-Cell Therapy Approach Stands Out, Analyst Sees Strong Potential
Via Benzinga
This Tevogen Bio Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Tevogen Bio to Receive $8 Million of Non-Dilutive Grant Funding, Reiterates Efficient Operations
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Shares 2024 Financing Activity on One Year Anniversary of Becoming a Publicly Listed Company; Highlights Operational Efficiency
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation’s Health and Prosperity
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Meets BARDA TechWatch Team, Highlighting ExacTcell™ Technology’s Potential as a Scalable Medical Countermeasure
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding
From Tevogen Bio Inc
Via GlobeNewswire
Which stocks are experiencing notable movement on Monday?
Via Chartmill
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
From Tevogen Bio Inc
Via GlobeNewswire
What's Going On With Tevogen Bio Stock Today?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
US Stock Futures Tumble As DeepSeek Buzz Jolts Big Tech: Expert Says The Chinese AI Model Is Yet To Prove Its Viability At Lower Cost In Long Term
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Tevogen Bio Holdings Inc. - Common Stock publicly traded?
Yes, Tevogen Bio Holdings Inc. - Common Stock is publicly traded.
What exchange does Tevogen Bio Holdings Inc. - Common Stock trade on?
Tevogen Bio Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tevogen Bio Holdings Inc. - Common Stock?
The ticker symbol for Tevogen Bio Holdings Inc. - Common Stock is TVGN on the Nasdaq Stock Market
What is the current price of Tevogen Bio Holdings Inc. - Common Stock?
The current price of Tevogen Bio Holdings Inc. - Common Stock is 1.080
When was Tevogen Bio Holdings Inc. - Common Stock last traded?
The last trade of Tevogen Bio Holdings Inc. - Common Stock was at 04/11/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.